Sabari, J.
1221  results:
Search for persons X
?
5

27P Amivantamab versus alternative real-world anti-cancer t..:

Girard, N. ; Wolf, J. ; Kim, T.M....
Journal of Thoracic Oncology.  18 (2023)  4 - p. S56 , 2023
 
?
6

8MO Adagrasib (MRTX849) in patients with advanced/metastati..:

Jänne, P.A. ; Spira, A. ; Riely, G.J....
Journal of Thoracic Oncology.  18 (2023)  4 - p. S41-S42 , 2023
 
?
7

30 Long-term efficacy, safety, and predictors of response t..:

Lopez, P. Garrido ; Girard, N. ; Cho, B.C....
Journal of Thoracic Oncology.  18 (2023)  4 - p. S36-S37 , 2023
 
?
8

EP12.01-38 Real-world Outcomes in a U.S. Asian Population w..:

Liu, Y. ; Bi, J. ; Moreira, A....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S655-S656 , 2023
 
?
9

PP01.31 Real-World Treatment Outcomes of Amivantamab in Pre..:

Sabari, J. ; Kim, T.M. ; Spira, A....
Journal of Thoracic Oncology.  18 (2023)  3 - p. e23 , 2023
 
?
10

19P Mortality among EGFR-mutated advanced NSCLC patients af..:

Girard, N. ; Leighl, N. ; Ohe, Y....
Journal of Thoracic Oncology.  18 (2023)  4 - p. S51-S52 , 2023
 
?
12

Study on permeability characteristics of soil and marble du..:

Sabari, D. ; Ramalakshmi, M.
Materials Today: Proceedings.  69 (2022)  - p. 837-842 , 2022
 
?
13

EP08.02-016 Frontline and Post-Osimertinib Therapy for EGFR..:

Girard, N. ; Besse, B. ; Bernabé Caro, R....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S404-S405 , 2022
 
?
 
?
15

EP08.02-173 Treatment Patterns and Outcomes Among Patients ..:

Sabari, J. ; Pisano, S. ; Gemmler, K....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S488-S489 , 2022
 
1-15